Phoenix, AZ, United States of America

Arlet Alarcon

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 8.0

ph-index = 6

Forward Citations = 98(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Arlet Alarcon in Molecular Profiling

Introduction

Arlet Alarcon, based in Phoenix, AZ, is an accomplished inventor known for her significant contributions to the field of molecular profiling, particularly in cancer research. With a remarkable portfolio of 9 patents, she continues to push the boundaries of medical innovation.

Latest Patents

Among her latest inventions is a groundbreaking patent focused on the "Molecular Profiling of Tumors." This invention outlines novel methods and systems for molecular profiling of diseases, such as cancer. It provides an innovative approach to identify treatments for diseases, including those that may not have been initially recognized as effective or expected treatments. This work is pivotal in enhancing treatment efficacy and personalizing healthcare.

Career Highlights

Arlet Alarcon is currently associated with Caris MPI, Inc., where she leverages her expertise to advance research and development in cancer diagnostics. Her role at the company enables her to collaborate with other leading experts in the field, contributing to significant advancements in medical technology.

Collaborations

Throughout her career, Arlet has collaborated with notable colleagues, including Daniel D. Von Hoff and David M. Loesch. These partnerships have fostered a collaborative environment focused on innovation and excellence in cancer research, amplifying the impact of her inventions.

Conclusion

Arlet Alarcon's dedication to innovation in molecular profiling not only showcases her talent as an inventor but also highlights the importance of her work in the fight against cancer. Her contributions continue to pave the way for new therapeutic strategies and improved patient outcomes in the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…